Genetic Technologies Ltd ADS - ADR Key Ratios
$0.77
As on 29-Jan-2025 09:30EDT
Market cap
$4 Mln
Revenue (TTM)
$14 Mln
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 100.00 | 5.90 | -1.91 | 89.33 | 183.15 |
| EBIT | -104.74 | 11.58 | 5.14 | -6.46 | -13.66 |
| Net Profit | -100.00 | 11.01 | -2.27 | -18.66 | -49.80 |
| EPS | -5,900.02 | 42.29 | 25.31 | -0.38 | 10.05 |
| Book Value | -- | -- | -89.37 | -62.96 | -27.41 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Jun-24 | Jun-23 | Jun-22 |
| EBIT-Margin
| -128.47 | -13,584.92 | -156.11 | -114.80 | -114.49 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -102.57 | -85.66 | -184.98 | -85.17 | -37.57 |
| Return on Capital
| -95.10 | -80.54 | -166.89 | -81.66 | -36.74 |
| Return on Assets
| -70.90 | -63.35 | -114.22 | -65.91 | -32.58 |
| Debt to Equity (x)
| -- | -- | 0.48 | 0.05 | 0.04 |
Profitability
ROCE
-166.89
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-166.89
|
-81.66
|
-36.74
|
-39.81
|
-77.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-184.98
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-184.98
|
-85.17
|
-37.57
|
-40.58
|
-79.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-114.22
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-114.22
|
-65.91
|
-32.58
|
-37.34
|
-66.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-156.11
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-156.11
|
-114.80
|
-114.49
|
-5,859.26
|
-61,679.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-156.78
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-156.78
|
-113.56
|
-104.95
|
-5,979.01
|
-63,909.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.26
--
Year on year growth in net sales
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-0.26
|
0.52
|
55.36
|
11.22
|
-0.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-0.72
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-0.72
|
-52.71
|
-10.13
|
-16.10
|
-1.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-2.27
--
Year on year growth in profit after tax
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-2.27
|
-64.79
|
1.07
|
-14.34
|
7.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.34
--
Year on year growth in earnings per share
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.34
|
-0.57
|
0.05
|
0.34
|
0.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.48
--
Total debt / Net worth
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.48
|
0.05
|
0.04
|
0.01
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.47
--
(Short term borrowings / Net worth)
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.47
|
0.03
|
0.02
|
0.01
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.88
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.88
|
3.17
|
3.86
|
15.82
|
10.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
0.83
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.83
|
3.07
|
3.76
|
15.77
|
10.81
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-231.79
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-231.79
|
-402.50
|
-511.29
|
-502.78
|
-410.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
27.74
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
27.74
|
1.85
|
35.63
|
891.16
|
394.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.73
--
Sales / Average Total Assets
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
0.73
|
0.58
|
0.31
|
0.01
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
55.24
--
Average Debtors / Sales * 365
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
55.24
|
46.12
|
93.95
|
1,686.36
|
1,025.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
25.85
--
Average Inventory / Sales * 365
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
25.85
|
30.50
|
270.10
|
85.14
|
89.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
111.52
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
111.52
|
83.91
|
809.31
|
313.53
|
682.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-30.42
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
Jun-20
|
|---|---|---|---|---|---|
|
Genetic Technologies Ltd ADS - ADR
|
-30.42
|
-7.29
|
-445.27
|
1,457.97
|
432.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|